AzTrials
AzTrials

Acute Lung InjuryPALIVE1NCT00521625

Epidemiologic Multicenter Study on Mechanical Ventilation Management in Children With Acute Lung Injury

An observational study of Acute Lung Injury and Acute Respiratory Distress Syndrome, run by St. Justine's Hospital at 58 sites in 12 countries.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

PALIVE 1 is an observational multicenter study on mechanical ventilation strategies used in children with an acute lung injury (ALI). The objective of the study is to describe mechanical ventilation strategies in children with an ALI. Read more about this study

Who is it for?
Ages Up to 18 years
How many people
Not given
Where
58 sitesin 12 countries
Study dates
Jun 2007to Nov 2007
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Up to 18 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • Child on invasive mechanical ventilation administered through an endotracheal tube or a tracheostomy tube, or on non-invasive mechanical ventilation administered through a nasal or facial mask or a nasal canula or helmet at 9 a.m. on the day of the study.
  • Presence of ALI as estimated by the attending physician:
  • Onset of hypoxemia was acute
  • Bilateral infiltrates on chest X-Ray
  • No clinical evidence of congestive heart failure
  • Sustained hypoxemia defined as:
Show all 9Show fewer
  • PaO2(mmHg)/FiO2 ratio ≤ 300 or PaO2(kPa)/FiO2 ≤ 40
  • If no arterial canula or no arterial blood gas:
  • SpO2/FiO2 ≤ 320 with SpO2 < 0.98 (10)

Who cannot join

  • Post conceptional age < 42 weeks
  • Age > 18 years
  • Non-corrected cyanotic congenital heart disease or evidence of extra-pulmonary right to left shunt
  • Withdrawal/withholding of care
  • Brain death
  • No consent, if required
  • Patient on ECMO
  • Already included in this study

Trial locations and contacts

58 sites in 12 countries.

58 sites in 12 countries

United States20 sites
  • Children's Hospital of Austin

    Austin, Texas

  • Children's Memorial Hospital

    Chicago, Illinois

  • The Children's Hospital

    Denver, Colorado

  • Duke University Medical Center

    Durham, North Carolina

  • Connecticut Children's Medical Center

    Hartford, Connecticut

  • Penn State Children's Hospital

    Hershey, Pennsylvania

  • Texas Childrens Hospital

    Houston, Texas

  • Riley Hospital for Children

    Indianapolis, Indiana

  • Children's Mercy Hospital

    Kansas City, Missouri

  • Darmouth-Hitchcock Medical Center

    Lebanon, New Hampshire

  • Kentucky Children's Hospital

    Lexington, Kentucky

  • Children's Hospital Los Angeles

    Los Angeles, California

  • Miami Children's Hospital

    Miami, Florida

  • Children's Hospital of Wisconsin

    Milwaukee, Wisconsin

  • New York Presbyterian Hospital

    New York, New York

  • Children's Hospital at Oakland

    Oakland, California

  • Children's Hospital

    Omaha, Nebraska

  • Nebraska Medical Center

    Omaha, Nebraska

  • The Children's hospital Philadelphia

    Philadelphia, Pennsylvania

  • UMAss Memorial Medical Center

    Worchester, Massachusetts

Other trials in United States

Canada8 sites
  • Stollery Children's Hospital

    Edmonton

  • McMaster Children's Hospital

    Hamilton

  • Children's Hospital of Western Ontario

    London

  • Hôpital SteJustine

    Montreal, Quebec

  • Montreal Children' Hospital

    Montreal, Quebec

  • Centre Hospitalier Universitaire de Quebec

    Québec

  • Centre Hospitalier Universitaire de Sherbrooke

    Sherbrooke, Quebec

  • BC Children's Hospital

    Vancouver

Other trials in Canada

Spain7 sites
  • Hospital Sant Joan de Déu-Hospital Clinic

    Barcelona

  • Cruces Hospital

    Bilbao

  • General University Hospital Gregorio Marañón

    Madrid

  • Hospital Universitario Central de Asturias

    Oveido

  • Hospital universitario de Salamanca

    Salamanca

  • Hospital Clínico Universitario de Santiago de Compostela

    Santiago de Compostela

  • Hospital Infantil La Fe

    Valencia

Other trials in Spain

France5 sites
  • CHU Lille

    Lille

  • CHU Nantes

    Nantes

  • Hôpital Robert-Debré

    Paris

  • Necker

    Paris

  • CHU Pontchaillou

    Rennes

Other trials in France

Germany5 sites
  • University Clinic Frankfurt

    Frankfurt

  • Universitätsklinikum Mannheim

    Mannheim

  • Kinderzentrum im Klinikum Nürnberg

    Nuremberg

  • Children's Hospital StAugustin

    Sankt Augustin

  • University Children's Hospital

    Tuebringen

Other trials in Germany

Italy3 sites
  • Ospedali riuniti di Bergamo

    Bergamo

  • Padua University Hospital

    Padova

  • Azienda Ospedaliera di Verona

    Verona

Other trials in Italy

Austria2 sites
  • Akademisches Lehrkrankenhaus

    Feldkirch

  • Medical University of Vienna

    Vienna

Other trials in Austria

Belgium2 sites
  • Paola Childrens Hospital

    Antwerp

  • Cliniques universitaires Saint-Luc

    Brussels

Other trials in Belgium

Sweden2 sites
  • The Queen Silvia Children's Hospital

    Gothenburg

  • Astrid Lindgren Children's Hospital

    Stockholm

Other trials in Sweden

Switzerland2 sites
  • Children's Hospital

    Geneva

  • Centre Hospitalier Universitaire Vaudois

    Lausanne

Other trials in Switzerland

Netherlands1 site
  • The Wilhelmina Children's Hospital

    Utrecht

Other trials in Netherlands

United Kingdom1 site
  • Bristol Children's Hospital

    Bristol

Other trials in United Kingdom

About this study

Official title: Epidemiologic Multicenter Study on Mechanical Ventilation Management in Children With Acute Lung Injury - Phase 1 PALIVE 1 (for Pediatric Acute Lung Injury Mechanical VEntilation Strategies)

PALIVE 1 is an observational multicenter study on mechanical ventilation strategies used in children with an acute lung injury (ALI). The objective of the study is to describe mechanical ventilation strategies in children with an ALI. Our hypothesis is that daily clinical practice is heterogenous among pediatric intensivists as few pediatric data exists on optimal mechanical ventilation strategies in this group of patients. Furthermore, different strategies may affect patient outcome.

Read the detailed description

INTRODUCTION Few pediatric data exists on the ventilation mode and parameters that would provide the greatest benefit with the least risk to an individual pediatric patient with Acute Lung Injury (ALI). Current expert opinion is that it is reasonable to follow adult recommendations and to adapt clinical management in children according to adult data. In the absence of consensus and established guidelines for mechanical ventilation in children with ALI, we believe that the daily clinical practice in pediatric intensive care units is subject to great variations according to the experience, comfort and knowledge of the attending intensivist.

METHODS Objective: Describe invasive and non-invasive mechanical ventilation in pediatric cases of ALI.

Hypothesis: There is an important variability in the observed practice pattern of mechanical ventilation in pediatric cases of ALI.

Design: An international cross-sectional epidemiologic study in Pediatric Intensive Care Units on the observed practice pattern of invasive and non-invasive mechanical ventilation in children with ALI.

Setting: Pediatric Intensive Care Units in Canada, United States, Europe.

Patients: Patients less than 18 years old on invasive or non-invasive mechanical ventilation with a diagnosis of ALI on the day of the study.

Measurements: Demographic data on included patients; their underlying chronic disease and acute disease leading to non-invasive mechanical ventilation or intubation and mechanical ventilation; data on mechanical ventilation mode and parameters, vital signs, lab results, radiographic findings, treatments, complications of mechanical ventilation will be recorded every 6 hours for 24 hours. A web based case report form will be developed.

Sample size: We plan to conduct the study on isolated days at least one month apart until we reach 200 patients with ALI, to include at least 10 patients on high frequency ventilation. We estimate that with 5 days of study in 70 centers we should reach this number.

FUTURE CONSIDERATIONS We believe this study will provide important data on the actual mechanical ventilation strategies in pediatric patients with ALI. The next step will be to conduct a prospective international study on mechanical ventilation strategies and to follow patients prospectively during the whole course of their mechanical ventilation.

Medical subject headings
Acute Lung Injury, Respiratory Distress Syndrome

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Aug 2007 (estimated)
  2. Study startJun 2007
  3. Study completionNov 2007

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Time perspective
Prospective
IDs, dates and publications
ClinicalTrials.gov ID
NCT00521625
Sponsor's protocol ID
PALIVE1
Acronym
PALIVE1
Status last verified
May 2008
First submitted
24 Aug 2007
Last updated
22 May 2008
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Acute Lung Injury and Acute Respiratory Distress Syndrome, run by St. Justine's Hospital at 58 sites in 12 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 May 2008. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 58 sites in United States, Canada, Spain, France, Germany and 7 more countries. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 May 2008.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in